| Product Name | MF | CAS | Details |
|---|
| (S)-N-(3-chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine | C18H14ClFN4O4 | 314771-88-5 | Details |
| 2-((2,6-dioxopiperidin-3-yl)carbamoyl)-6-nitrobenzoic acid | C13H11N3O7 | Details |
| Isoquinoline-5-sulphonyl chloride hydrochloride | C9H7Cl2NO2S | 105627-79-0 | Details |
| parecoxib impurity D | Details |
| parecoxib impurity I | Details |
| Tenofovir Alafenamide Fumarate | C25H33N6O9P | 1392275-56-7 | Details |
| parecoxib impurity L | Details |
| Vonoprazan | C17H16FN3O2S | 881681-00-1 | Details |
| parecoxib impurity A | Details |
| parecoxib impurity F | Details |
| 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | C13H20ClN | 312753-53-0 | Details |
| Pomalidomid,4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C13H11N3O4 | 19171-19-8 | Details |
| Aspartic acid condensate | C8H12N2O7 | 60079-22-3 | Details |
| parecoxib impurity M | Details |
| Fumarate rich fumarate full set of impurities | Details |
| 2-(2,6-dioxopiperidin-3-yl)-4-(hydroxyamino)isoindoline-1,3-dione | C13H11N3O5 | 497147-11-2 | Details |
| (R)-5-methyl-2-(propan-2-ylidene)cyclohexanone | C10H16O | 89-82-7 | Details |
| Indacaterol interMediate | C31H34N2O3 | 435273-75-9 | Details |
| 1,4-bis(isoquinolin-5-ylsulfonyl)-1,4-diazepane | C23H22N4O4S2 | 1337967-93-7 | Details |
| 2-(2,6-dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione | C13H9N3O6 | 19171-18-7 | Details |
| Methyl 2-(2-hydroxy-4,5-diMethoxybenzaMido)thiazole-4-carboxylate | C14H14N2O6S | 877997-99-4 | Details |
| parecoxib impurity J | Details |
| parecoxib impurity E | Details |
| (R)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxy-3,4-dihydroquinolin-2(1H)-one | C24H30N2O3 | Details |
| phenyl 2-hydroxy-4,5-dimethoxybenzoate | C15H14O5 | 877997-98-3 | Details |
| Acotiamide hydrochloride trihydrate | C21H31ClN4O5S | 773092-05-0 | Details |
| (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C22H22N6O | 1022150-12-4 | Details |
| Fasudil hydrochloride | C14H18ClN3O2S | 105628-07-7 | Details |
| parecoxib impurity N | Details |
| 5-((1R)-2-((5-ethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one | C22H24N2O3 | Details |
| 2(1H)-Quinolinone, 5-(2R)-oxiranyl-8-(phenylmethoxy)- | C18H15NO3 | 173140-90-4 | Details |
| 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C17H13N5O | 330786-24-8 | Details |
| N-(2-(diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide hydrochloride | C21H30N4O5S | 185106-16-5 | Details |
| (R)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-ethoxyethyl)-8-hydroxyquinolin-2(1H)-one | C26H32N2O3 | Details |
| parecoxib impurity C | 3026677-40-4 | Details |
| parecoxib impurity H | C22H23N3O7S2 | 1708094-99-8 | Details |
| parecoxib impurity G | C16H14N2O3S | 386273-25-2 | Details |
| (+)-L-TARTARIC ACID DIBENZYL AMIDE | C18H20N2O4 | 88393-56-0 | Details |
| parecoxib impurity K | C17H16N2O3S | 198471-69-1 | Details |
| parecoxib impurity B | Details |
| Product Total： Product Page： | ||||
| 1 | ||||